Treatments Beyond Surgery: Early-stage Options from ASCO 2022

2022-06-27T06:16:53-05:00June 27th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Authors: Andrew Ciupek, PhD, Associate Director, Clinical Research and Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program People who are diagnosed with early stage (stage 1-2) non-small cell lung cancer (NSCLC) are generally broken down into two groups: those [...]

Go to Top